STOCK TITAN

Medline: Capital Research Global Investors owns 5.4%

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Medline Inc. (MDLN) is the issuer whose common stock is the subject of Capital Research Global Investors’ Schedule 13G reporting beneficial ownership of 47,768,233 shares, or 5.4% of the class. CRGI reported sole voting power over 47,724,358 shares and sole dispositive power over 47,768,233 shares, with no shared voting or dispositive power. CRGI said the percentage was based on 877,351,218 shares believed to be outstanding.

Beneficial ownership 47,768,233 shares Medline common stock
Percent of class 5.4% Based on 877,351,218 shares believed to be outstanding
Sole voting power 47,724,358 shares Shares of Medline common stock
Shares believed outstanding 877,351,218 shares Basis stated for the reported 5.4% ownership
beneficial owner regulatory
"deemed to be the beneficial owner of 47,768,233 shares"
A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.
dispositive power regulatory
"Sole power to dispose or to direct the disposition"
Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many MDLN shares did Capital Research Global Investors report owning?

Capital Research Global Investors reported beneficial ownership of 47,768,233 Medline shares, representing 5.4% of the class. It based that percentage on 877,351,218 shares believed to be outstanding.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





58507V107

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G



Capital Research Global Investors
Signature:Jae Won Chung
Name/Title:Senior Vice President and Associate General Counsel, Capital Research and Management Company
Date:11/13/2026

Keep reading